Work Here?
Overview
TurnCare delivers B2B healthcare technology for high-acuity patients. Its core product, the Guardian System, is a therapeutic patient support surface that uses the VasoTactic algorithm to apply dynamic pressure gradients to the sacral region, helping maintain blood flow and reduce pressure injuries, and it includes an inflatable surface, a controller, and a real-time data dashboard. The company differentiates itself with its proprietary VasoTactic tech, data-driven decision support, and a usage-based payment model managed with Monetize360. Its goal is to reduce hospital-acquired pressure injuries, shorten hospital stays, and improve patient safety and throughput in acute care settings.
About TurnCare
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
Pequannock Township, New Jersey
Founded
2019
Simplify's Take
What believers are saying
- TurnCare presented new real-world evidence at ISPOR 2026, strengthening reimbursement conversations.
- TurnCare appointed Andrew Clark CFO and Brandon McCray-Reeves commercial VP in December 2025.
- John F. Milligan joined the board in January 2024, adding Gilead-scale commercialization credibility.
What critics are saying
- FDA posted an open Guardian 2 recall in June 2025 for battery-alert software failure.
- TurnCare admits Guardian has not been studied in a large-scale trial replacing Q2 repositioning.
- U.S.-only availability and rental pricing cap expansion; hospitals can standardize on cheaper mattresses.
What makes TurnCare unique
- Guardian targets sacral pressure injuries with dynamic blood-flow therapy, not generic alternating pressure.
- TurnCare bundles therapy hardware, dashboards, and utilization data into one hospital workflow.
- Usage-based rental pricing aligns hospital spend to patient episodes, lowering adoption friction.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Flexible Work Hours
Company News
PALO ALTO, Calif., Jan. 11, 2024 /PRNewswire/ -- TurnCare, a leading medical technology and services company dedicated to advancing how hospitals manage high acuity patients, is proud to announce the addition of John F. Milligan, Ph.D., investor, innovator, and former CEO of Gilead, to its Board of Directors.Dr. Milligan, a seasoned industry veteran, played a pivotal role in growing Gilead from an early-stage private company into a multi-billion-dollar business with a global footprint. Dr. Milligan's contributions and expertise include the development of breakthrough new therapies to address healthcare epidemics like HIV and HCV, driving major acquisitions to create unique industry solutions, and scaling Gilead to over $21 Billion in worldwide sales with a market cap of $85 Billion
TurnCare is Hiring for 4 Jobs on Simplify!
Find jobs on Simplify and start your career today
About TurnCare
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
Pequannock Township, New Jersey
Founded
2019
TurnCare is Hiring for 4 Jobs on Simplify!
Find jobs on Simplify and start your career today